Impairments in Brain-Derived Neurotrophic Factor-Induced Glutamate Release in Cultured Cortical Neurons Derived from Rats with Intrauterine Growth Retardation: Possible Involvement of Suppression of TrkB/Phospholipase C-γ Activation

2014 ◽  
Vol 39 (4) ◽  
pp. 785-792 ◽  
Author(s):  
Tadahiro Numakawa ◽  
Tomoya Matsumoto ◽  
Yoshiko Ooshima ◽  
Shuichi Chiba ◽  
Miyako Furuta ◽  
...  
2011 ◽  
Vol 71 ◽  
pp. e136-e137
Author(s):  
Yoshiko Ooshima ◽  
Tadahiro Numakawa ◽  
Shuichi Chiba ◽  
Miyako Furuta ◽  
Naoki Adachi ◽  
...  

2008 ◽  
Vol 79 (3) ◽  
pp. 522-530 ◽  
Author(s):  
Tomoya Matsumoto ◽  
Tadahiro Numakawa ◽  
Naoki Adachi ◽  
Daisaku Yokomaku ◽  
Satoru Yamagishi ◽  
...  

2019 ◽  
Vol 68 (1) ◽  
pp. 29-36 ◽  
Author(s):  
Antonina Yu. Morozova ◽  
Yulia P. Milyutina ◽  
Olga V. Kovalchuk-Kovalevskaya ◽  
Alexandr V. Arutjunyan ◽  
Inna I. Evsyukova

Neuron-specific enolase (NSE) and brain-derived neurotrophic factor (BDNF) levels in umbilical cord blood in full-term newborns with asymmetrical intrauterine growth retardation resulted from chronic placental insufficiency have been studied. Not only a 2.0–2.5-fold increase in the blood NSE level, but also a reduction in BDNF levels were observed, indicating brain damage combined with the lack of adequate compensatory capabilities. With an increase in the duration of intrauterine fetal development under conditions of chronic hypoxia, the degree of damage to neuronal structures increases. This article discusses the mechanisms of the revealed changes, as well as the diagnostic and prognostic significance of the use of biochemical markers.


2011 ◽  
Vol 286 (18) ◽  
pp. 16272-16284 ◽  
Author(s):  
Miao Yang ◽  
Yoon Lim ◽  
Xiaojiang Li ◽  
Jin-Hua Zhong ◽  
Xin-Fu Zhou

proBDNF, a precursor of brain-derived neurotrophic factor (BDNF), is anterogradely transported and released from nerve terminals, but the mechanism underlying this process remains unclear. In this study, we report that proBDNF forms a complex with Huntingtin associated protein-1 (HAP1) and sortilin, which plays an important role in proBDNF intracellular trafficking and stabilization. The interaction of proBDNF with both HAP1A and sortilin in co-transfected HEK293 cells is confirmed by both fluorescence resonance energy transfer and co-immunoprecipitation. The frequent co-localization (>90%) of endogenous HAP1, sortilin, and proBDNF is also found in cultured cortical neurons. Mapping studies using GST pulldown and competition assays has defined the interacting region of HAP1 with proBDNF within amino acids 371–445 and the binding sequences of proBDNF to HAP1 between amino acids 65 and 90. Fluorescence recovery after photobleaching confirms the defective movement of proBDNF-containing vesicles in neurites of HAP1−/− neurons, which can be partially restored by reintroducing HAP1 cDNA into the neurons. However, the effect is significantly increased by simultaneously reintroducing both HAP1 and sortilin. proBDNF and HAP1 are highly co-localized with organelle markers for the Golgi network, microtubules, molecular motor, or endosomes in normal neurons, but this co-localization is reduced in HAP1−/− neurons. Co-immunoprecipitation and Western blot showed that sortilin stabilizes the proBDNF·HAP1 complex in co-transfected HEK293 cells, helping to prevent proBDNF degradation. Furthermore, the complex facilitates furin cleavage to release mature BDNF.


2009 ◽  
Vol 30 (2) ◽  
pp. 286-298 ◽  
Author(s):  
Camille Robinet ◽  
Luc Pellerin

MCT2 is the predominant neuronal monocarboxylate transporter allowing lactate use as an alternative energy substrate. It is suggested that MCT2 is upregulated to meet enhanced energy demands after modifications in synaptic transmission. Brain-derived neurotrophic factor (BDNF), a promoter of synaptic plasticity, significantly increased MCT2 protein expression in cultured cortical neurons (as shown by immunocytochemistry and western blot) through a translational regulation at the synaptic level. Brain-derived neurotrophic factor can cause translational activation through different signaling pathways. Western blot analyses showed that p44/p42 mitogen-activated protein kinase (MAPK), Akt, and S6 were strongly phosphorylated on BDNF treatment. To determine by which signal transduction pathway(s) BDNF mediates its upregulation of MCT2 protein expression, the effect of specific inhibitors for p38 MAPK, phosphoinositide 3-kinase (PI3K), mammalian target of rapamycin (mTOR), mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase (MEK), p44/p42 MAPK (ERK), and Janus kinase 2 (JAK2) was evaluated. It could be observed that the BDNF-induced increase in MCT2 protein expression was almost completely blocked by all inhibitors, except for JAK2. These data indicate that BDNF induces an increase in neuronal MCT2 protein expression by a mechanism involving a concomitant stimulation of PI3K/Akt/mTOR/S6, p38 MAPK, and p44/p42 MAPK. Moreover, our observations suggest that changes in MCT2 expression could participate in the process of synaptic plasticity induced by BDNF.


2010 ◽  
Vol 476 (2) ◽  
pp. 104-109 ◽  
Author(s):  
Midori Ninomiya ◽  
Tadahiro Numakawa ◽  
Naoki Adachi ◽  
Miyako Furuta ◽  
Shuichi Chiba ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document